Apimeds Pharmaceuticals US, Inc. (APUS): SCHEDULE 13G filed Feb 11, 2026

Name: Apimeds Pharmaceuticals US, Inc. SCHEDULE 13G (0001493152-26-006136)
Creator: Apimeds Pharmaceuticals US, Inc.
Published: 2026-02-11

Form type: SCHEDULE 13G
Filing date: Feb 11, 2026
Accession number: 0001493152-26-006136
Filer: Apimeds Pharmaceuticals US, Inc. (CIK 1894525)